These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 21856931
1. Ncb2 is involved in activated transcription of CDR1 in azole-resistant clinical isolates of Candida albicans. Shukla S, Yadav V, Mukhopadhyay G, Prasad R. Eukaryot Cell; 2011 Oct; 10(10):1357-66. PubMed ID: 21856931 [Abstract] [Full Text] [Related]
2. The global regulator Ncb2 escapes from the core promoter and impacts transcription in response to drug stress in Candida albicans. Shariq M, Dhamgaye S, Nair R, Goyal N, Jain V, Mukhopadhyay A, Mondal AK, Mukhopadhyay G, Prasad R. Sci Rep; 2017 Apr 06; 7():46084. PubMed ID: 28383050 [Abstract] [Full Text] [Related]
4. PAP1 [poly(A) polymerase 1] homozygosity and hyperadenylation are major determinants of increased mRNA stability of CDR1 in azole-resistant clinical isolates of Candida albicans. Manoharlal R, Gorantala J, Sharma M, Sanglard D, Prasad R. Microbiology (Reading); 2010 Feb 06; 156(Pt 2):313-326. PubMed ID: 19910410 [Abstract] [Full Text] [Related]
5. Mediator Tail Module Is Required for Tac1-Activated CDR1 Expression and Azole Resistance in Candida albicans. Liu Z, Myers LC. Antimicrob Agents Chemother; 2017 Nov 06; 61(11):. PubMed ID: 28807920 [Abstract] [Full Text] [Related]
7. TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. Coste AT, Karababa M, Ischer F, Bille J, Sanglard D. Eukaryot Cell; 2004 Dec 06; 3(6):1639-52. PubMed ID: 15590837 [Abstract] [Full Text] [Related]
8. Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters. Karababa M, Coste AT, Rognon B, Bille J, Sanglard D. Antimicrob Agents Chemother; 2004 Aug 06; 48(8):3064-79. PubMed ID: 15273122 [Abstract] [Full Text] [Related]
9. Increased expression and hotspot mutations of the multidrug efflux transporter, CDR1 in azole-resistant Candida albicans isolates from vaginitis patients. Looi CY, D' Silva EC, Seow HF, Rosli R, Ng KP, Chong PP. FEMS Microbiol Lett; 2005 Aug 15; 249(2):283-9. PubMed ID: 16006060 [Abstract] [Full Text] [Related]
10. The TAC1 Gene in Candida albicans: Structure, Function, and Role in Azole Resistance: A Mini-Review. Mahdizade AH, Hoseinnejad A, Ghazanfari M, Boozhmehrani MJ, Bahreiny SS, Abastabar M, Galbo R, Giuffrè L, Haghani I, Romeo O. Microb Drug Resist; 2024 Jul 15; 30(7):288-296. PubMed ID: 38770776 [Abstract] [Full Text] [Related]
11. Contribution of Clinically Derived Mutations in the Gene Encoding the Zinc Cluster Transcription Factor Mrr2 to Fluconazole Antifungal Resistance and CDR1 Expression in Candida albicans. Nishimoto AT, Zhang Q, Hazlett B, Morschhäuser J, Rogers PD. Antimicrob Agents Chemother; 2019 May 15; 63(5):. PubMed ID: 30833425 [Abstract] [Full Text] [Related]
12. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M, Bille J. Antimicrob Agents Chemother; 1995 Nov 15; 39(11):2378-86. PubMed ID: 8585712 [Abstract] [Full Text] [Related]
13. Mutations in transcription factor Mrr2p contribute to fluconazole resistance in clinical isolates of Candida albicans. Wang Y, Liu JY, Shi C, Li WJ, Zhao Y, Yan L, Xiang MJ. Int J Antimicrob Agents; 2015 Nov 15; 46(5):552-9. PubMed ID: 26404130 [Abstract] [Full Text] [Related]
14. Candida albicans Zn Cluster Transcription Factors Tac1 and Znc1 Are Activated by Farnesol To Upregulate a Transcriptional Program Including the Multidrug Efflux Pump CDR1. Liu Z, Rossi JM, Myers LC. Antimicrob Agents Chemother; 2018 Nov 15; 62(11):. PubMed ID: 30104273 [Abstract] [Full Text] [Related]
15. Berberine inhibits fluphenazine-induced up-regulation of CDR1 in Candida albicans. Zhu SL, Yan L, Zhang YX, Jiang ZH, Gao PH, Qiu Y, Wang L, Zhao MZ, Ni TJ, Cai Z, Tian SJ, Zang CX, Zhang DZ, Jiang YY. Biol Pharm Bull; 2014 Nov 15; 37(2):268-73. PubMed ID: 24492724 [Abstract] [Full Text] [Related]
16. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India. Mane A, Vidhate P, Kusro C, Waman V, Saxena V, Kulkarni-Kale U, Risbud A. Mycoses; 2016 Feb 15; 59(2):93-100. PubMed ID: 26648048 [Abstract] [Full Text] [Related]
17. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies. Vermitsky JP, Earhart KD, Smith WL, Homayouni R, Edlind TD, Rogers PD. Mol Microbiol; 2006 Aug 15; 61(3):704-22. PubMed ID: 16803598 [Abstract] [Full Text] [Related]
18. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms. Sanglard D, Coste AT. Antimicrob Agents Chemother; 2016 Jan 15; 60(1):229-38. PubMed ID: 26482310 [Abstract] [Full Text] [Related]
19. Genetic Analysis of Candida auris Implicates Hsp90 in Morphogenesis and Azole Tolerance and Cdr1 in Azole Resistance. Kim SH, Iyer KR, Pardeshi L, Muñoz JF, Robbins N, Cuomo CA, Wong KH, Cowen LE. mBio; 2019 Jan 29; 10(1):. PubMed ID: 30696744 [Abstract] [Full Text] [Related]
20. SRE1 and SRE2 are two specific steroid-responsive modules of Candida drug resistance gene 1 (CDR1) promoter. Karnani N, Gaur NA, Jha S, Puri N, Krishnamurthy S, Goswami SK, Mukhopadhyay G, Prasad R. Yeast; 2004 Feb 29; 21(3):219-39. PubMed ID: 14968428 [Abstract] [Full Text] [Related] Page: [Next] [New Search]